Annuncio pubblicitario
Italia markets close in 48 minutes

  • FTSE MIB

    33.902,35
    -368,77 (-1,08%)
     

  • Dow Jones

    37.763,15
    -697,77 (-1,81%)
     

  • Nasdaq

    15.435,81
    -276,94 (-1,76%)
     

  • Nikkei 225

    37.628,48
    -831,60 (-2,16%)
     

  • Petrolio

    82,25
    -0,56 (-0,68%)
     

  • Bitcoin EUR

    59.240,97
    -1.395,61 (-2,30%)
     

  • CMC Crypto 200

    1.379,54
    -3,04 (-0,22%)
     

  • Oro

    2.344,30
    +5,90 (+0,25%)
     

  • EUR/USD

    1,0717
    +0,0016 (+0,15%)
     

  • S&P 500

    4.999,97
    -71,66 (-1,41%)
     

  • HANG SENG

    17.284,54
    +83,27 (+0,48%)
     

  • Euro Stoxx 50

    4.928,57
    -61,31 (-1,23%)
     

  • EUR/GBP

    0,8575
    -0,0008 (-0,09%)
     

  • EUR/CHF

    0,9792
    +0,0009 (+0,09%)
     

  • EUR/CAD

    1,4684
    +0,0028 (+0,19%)
     

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of Co-Diagnostics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of August 17, 2020 - CODX

Newsfile Corp.
·2 minuto per la lettura

New York, New York--(Newsfile Corp. - July 7, 2020) - The following statement is being issued by Levi & Korsinsky, LLP:

To: All persons or entities who purchased or otherwise acquired securities of Co-Diagnostics, Inc. ("Co-Diagnostics") (NASDAQ: CODX) between February 25, 2020 and May 15, 2020. You are hereby notified that a securities class action lawsuit has been commenced in the the United States District Court for the District of Utah. To get more information go to:

https://www.zlk.com/pslra-1/co-diagnostics-inc-loss-submission-form?prid=7827&wire=5

or contact Joseph E. Levi, Esq. either via email at jlevi@levikorsinsky.com or by telephone at (212) 363-7500. There is no cost or obligation to you.

According to the filed complaint, Co-Diagnostics and its directors and officers (including PhD-level scientists who should know better) made continual, knowing, and willful misstatements about the Company's main product, a Covid-19 diagnostic test. These misstatements had the effect of pumping up the price of Co-Diagnostics' stock while Company officers and directors exercised low-priced options and dumped their stock into the market. Co-Diagnostics' fraudulent misstatements displayed a disregard for basic scientific principles and caused investors to lose millions of dollars.

ANNUNCIO PUBBLICITARIO

If you suffered a loss in Co-Diagnostics you have until August 17, 2020 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Levi & Korsinsky is a nationally recognized firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/59326